NARKOSEFORMULIERUNG

Patent europeic · EP2525798 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2525798
Numer da la dumonda
EP11734245
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-01-2011
Publitgà
28-11-2012
Concedì
09-08-2017
La protecziun finescha il pli tard
18-01-2031
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61K 31/56 (2006.01)
A61K 47/40 (2006.01)
A61K 31/57 (2006.01)
A61P 23/00 (2006.01)
Prioritad
US 385318 P 22.09.2010
US 297249 P 21.01.2010
Dumonda PCT
PCT/AU2011/000050 19.01.2011
Publicaziun PCT
WO2011/088503 28.07.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 14-07-2023

    Midada

    Published in Swissreg on 14.07.2023

  5. 09-08-2022

    Midada

    Published in Swissreg on 09.08.2022

  6. 22-09-2021

    Transferì

    Owner
    Drawbridge Pharmaceuticals Pty Ltd., Level 33, 360 Collins Street, Melbourne VIC 3000, Australia → Drawbridge Pharmaceuticals Pty Ltd., 23 Milton Parade, Malvern VIC 3144, Australia

    Published in Swissreg on 22.09.2021

  7. 09-08-2017

    Concedì

    Published in Swissreg on 09.08.2017

Partidas

Possessur

Drawbridge Pharmaceuticals Pty Ltd.

23 Milton Parade, Malvern VIC 3144, AU

Inventur

GOODCHILD, Juliet Marguerite

Malvern Victoria 3144, AU

GOODCHILD, Colin Stanley

Malvern Victoria 3144, AU

BOYD, Benjamin James

Warrandyte Victoria 3113, AU

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.